Ignite Creation Date:
2024-05-06 @ 3:33 AM
Last Modification Date:
2024-10-26 @ 11:35 AM
Study NCT ID:
NCT02319369
Status:
TERMINATED
Last Update Posted:
2021-10-11
First Post:
2014-12-15
Brief Title:
Safety Tolerability and Pharmacokinetics of Milademetan Alone and With 5-Azacitidine AZA in Acute Myelogenous Leukemia AML or High-Risk Myelodysplastic Syndrome MDS
Sponsor:
Daiichi Sankyo
Organization:
Daiichi Sankyo
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-11-25
Start Date Type:
ACTUAL
Primary Completion Date:
2020-08-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-08-21
Completion Date Type:
ACTUAL
First Submit Date:
2014-12-15
First Submit QC Date:
December 17 2014
Study First Post Date:
2014-12-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2021-10-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-09-14
Last Update Post Date:
2021-10-11
Last Update Post Date Type:
ACTUAL